Opinion statement
Venous thromboembolism is a common problem in hospital and community patients and is associated with longer hospital stays, significant morbidity, and mortality. It is the third most common cardiovascular disease after ischemic coronary artery disease and stroke. A quarter of patients with acute myocardial infarction and more than half of patients with acute ischemic stroke may develop venous thromboembolism. The traditional treatment of venous thrombosis has been with anticoagulation, initially with heparin, followed by warfarin long term. The concept of thrombolysis for venous thrombosis is relatively new, but its exact role remains unsettled and largely unexplored. Reports of catheter fragmentation with systemic thrombolysis as well as catheter-directed thrombolysis are promising, and groups of patients who would benefit from thrombolytic therapy as the primary treatment are now being identified.
Similar content being viewed by others
References and Recommended Reading
Arcasoy SM, Vachani A: Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 2003, 24:73–91. A good overview of venous thrombolysis, with results of recent trials in thrombolysis.
Olin JW: Pulmonary embolism. Rev Cardiovasc Med 2002, 3(suppl 2):S68-S75.
Egermayer P: The effects of heparin and oral anticoagulants on thrombus propagation and prevention of the postphlebitic syndrome: a critical review of the literature. Prog Cardiovasc Dis 2001, 44:69–80.
Qari M, Abdel-Razeq H, Alzeer A, et al.: Recent advances in the diagnosis and treatment of deep vein thrombosis: a regional consensus. Curr Opin Investig Drugs 2003, 4:309–315.
Saarinen J, Kallio T, Lehto M, et al.: The occurrence of the post-thrombotic changes after an acute deep venous thrombosis. A prospective two-year follow-up study. J Cardiovasc Surg (Torino) 2000, 41:441–446.
Girolami A, Prandoni P, Zanon E, et al.: Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. Blood Coagul Fibrinolysis 1999, 10:455–457.
Seligsohn U, Lubetsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 2001, 344:1222–1231.
Turpie AG, Chin BS, Lip GY: Venous thromboembolism: pathophysiology, clinical features, and prevention. In ABC of Antithrombotic Therapy. Edited by Lip GY, Blann AD. London: BMJ Books; 2003:9–13.
McLean J: The thromboplastic action of cephalin. Am J Physiol 1912, 41:250.
Ryan TJ, Antman EM, Brooks NH, et al.: 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999, 34:890–911.
Merli G, Spiro TE, Olsson CG, et al.: Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001, 134:191–202.
Elliott G: Thrombolytic therapy for venous thromboembolism. Curr Opin Hematol 1999, 6:304–308.
Joffe HV, Goldhaber SZ: Upper-extremity deep vein thrombosis. Circulation 2002, 106:1874–1880.
Kasirajan K, Gray B, Ouriel K: Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001, 12:179–185.
Francis CW, Suchkova VN: Ultrasound and thrombolysis. Vasc Med 2001, 6:181–187.
Baker WF Jr: Thrombolytic therapy. Clin Appl Thromb Hemost 2002, 8:291–314. State-of-the-art review that looks at pathways of fibrinolysis, structure, pharmacology, and function of thrombolytic agents.
Ouriel K, Gray B, Clair DG, Olin J: Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000, 11:295–298.
Ouriel K: Comparison of safety and efficacy of the various thrombolytic agents. Thrombolytic solutions. Rev Cardiovasc Med 2002, 3(suppl 2):S17-S24.
Swischuk JL, Fox PF, Young K, et al.: Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 2001, 12:423–430.
Arepally A, Hofmann LV, Kim HS, et al.: Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions. J Vasc Interv Radiol 2002, 13:45–50.
Turpie AG, Chin BS, Lip GY: Venous thromboembolism: treatment strategies. In ABC of Antithrombotic Therapy. Edited by Lip GY, Blann AD. London: BMJ Books; 2003:13–15.
Coulter SA, Cannon CP, Ault KA, et al.: High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation 2000, 101:2690–2695.
Sugimoto K, Hofmann LV, Razavi MK, et al.: The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 2003, 37:512–517.
Thomas SM, Gaines PA: Vascular surgical society of great britain and ireland: avoiding the complications of hrombolysis. Br J Surg 1999, 86:710.
Wlodarczyk ZK, Gibson M, Dick R, Hamilton G: Low-dose intra-arterial thrombolysis in the treatment of phlegmasia caerulea dolens. Br J Surg 1994, 81:370–372.
Castaneda F, Li R, Young K, et al.: Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. J Vasc Interv Radiol 2002, 13:577–580.
Ouriel K, Katzen B, Mewissen M, et al.: Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol 2000, 11:849–854.
Arcasoy SM, Kreit JW: Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999, 115:1695–1707.
Mewissen MW: Thrombolytic therapy for lower extremity deep vein thrombosis and the North American Venous Registry. Semin Interv Radiol 2001, 18:139–144.
Schweizer J, Kirch W, Koch R, et al.: Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 2000, 36:1336–1343.
Subramanian R, White CJ: Mechanical interventions and thrombolytic therapy in venous thrombosis and pulmonary embolism. Ochsner J 2002, 4:30–36.
Wood KE: Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002, 121:877–905.
Sharma GV, Folland ED, McIntyre KM, Sasahara AA: Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med 2000, 5:91–95.
Hamel E, Pacouret G, Vincentelli D, et al.: Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001, 120:120–125.
De Gregorio MA, Gimeno MJ, Mainar A, et al.: Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol 2002, 13(2 Pt 1):163–169.
Wells PS, Forster AJ: Thrombolysis in deep vein thrombosis: is there still an indication? Thromb Haemost 2001, 86:499–508.
Comerota AJ, Throm RC, Mathias SD, et al.: Catheterdirected thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000, 32:130–137.
Mewissen MW, Seabrook GR, Meissner MH, et al.: Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999, 211:39–49.
Schneider DB, Curry TK, Eichler CM, et al.: Percutaneous mechanical thrombectomy for the management of venous thoracic outlet syndrome. J Endovasc Ther 2003, 10:336–340.
Angle N, Gelabert HA, Farooq MM, et al.: Safety and efficacy of early surgical decompression of the thoracic outlet for Paget-Schroetter syndrome. Ann Vasc Surg 2001, 15:37–42.
Urschel HC Jr, Razzuk MA: Paget-Schroetter syndrome: what is the best management? Ann Thorac Surg 2000, 69:1663–1668.
Delomez M, Beregi JP, Willoteaux S, et al.: Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovasc Intervent Radiol 2001, 24:42–48.
Ramaiah V, Del Santo PB, Rodriguez-Lopez JA, et al.: Trellis thrombectomy system for the treatment of iliofemoral deep venous thrombosis. J Endovasc Ther 2003, 10:585–589.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Menon, J., Salman, M.M. & Hamilton, G. Venous thrombolysis: Current perspectives. Curr Treat Options Cardio Med 6, 159–168 (2004). https://doi.org/10.1007/s11936-004-0044-1
Issue Date:
DOI: https://doi.org/10.1007/s11936-004-0044-1